The short version
6 companies supply this market — a reasonable cushion if one runs into trouble.
Market view
doxazosin mesylate · Powder
6 marketed package NDCs · 6 active manufacturers
Most dispensed: 4 mg · Tablet · #100 tablets/bottle · 1 mg · Tablet · #100 tablets/bottle · 8 mg · Tablet · #100 tablets/bottle · 2 mg · Tablet · #100 tablets/bottle
What changed in the last 90 days
Every detected change for doxazosin mesylate, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.
- Doxazosin mesylateAug 19, 2026Price downNADAC $0.10707 → $0.10009 per unit (-6.52%)
- Doxazosin mesylateAug 19, 2026Price downNADAC $0.08991 → $0.08566 per unit (-4.73%)
- Doxazosin mesylateAug 19, 2026Price downNADAC $0.06814 → $0.06564 per unit (-3.67%)
- Doxazosin mesylateAug 19, 2026Price downNADAC $0.08264 → $0.07725 per unit (-6.52%)
- Doxazosin mesylateAug 19, 2026Price downNADAC $0.08991 → $0.08566 per unit (-4.73%)
- Doxazosin mesylateAug 19, 2026Price downNADAC $0.08264 → $0.07725 per unit (-6.52%)
- DoxazosinAug 19, 2026Price downNADAC $0.10707 → $0.10009 per unit (-6.52%)
- DoxazosinAug 19, 2026Price downNADAC $0.10707 → $0.10009 per unit (-6.52%)
- DoxazosinAug 19, 2026Price downNADAC $0.08991 → $0.08566 per unit (-4.73%)
- DoxazosinAug 19, 2026Price downNADAC $0.06814 → $0.06564 per unit (-3.67%)
Same drug class
Other molecules FDA puts in alpha-Adrenergic Blocker, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
- alfuzosin hcl· 1 maker
- prazosin· 1 maker
- prazosin hcl· 2 makers
- dutasteride and tamsulosin hydrochloride· 5 makers
- terazosin· 11 makers
- phenoxybenzamine hydrochloride· 12 makers
- carvedilol phosphate· 15 makers
- alfuzosin hydrochloride· 17 makers
- terazosin hydrochloride· 18 makers
- silodosin· 21 makers
- phentolamine mesylate· 23 makers
- doxazosin· 27 makers
Common questions
- Is Doxazosin mesylate in shortage right now?
- No. FDA does not currently list Doxazosin mesylate in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
- Who makes Doxazosin mesylate?
- 17 companies have marketed Doxazosin mesylate in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.
- What does Doxazosin mesylate cost?
- The typical pharmacy pays about $0.0815 per unit, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.